Champions Oncology (CSBR) Other Non-Current Assets (2011 - 2026)
Champions Oncology's (CSBR) quarterly Other Non-Current Assets came in at $201000.0 in Q3 2026, up 2.55% year-over-year from $196000.0 in Q3 2025, and down 5.19% on a QoQ basis from $212000.0 in Q2 2026.
Powered by 
Analysis
Champions Oncology (CSBR) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Champions Oncology (CSBR) has 16 years of Other Non-Current Assets data on file, last reported at $201000.0 in Q3 2026.
- On a quarterly basis, Other Non-Current Assets rose 2.55% year-over-year to $201000.0 in Q3 2026; TTM through Jul 2026 was $201000.0, a 2.55% increase from a year earlier, with the FY2026 full-year figure at $212000.0, up 8.16% from the prior year.
- Other Non-Current Assets for Q3 2026 stood at $201000.0, down from $212000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $212000.0 in Q2 2026 and bottomed at $15000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $135842.1 across 5 years, with a median of $185000.0 in 2023.
- The widest annual swing landed in 2022, when Other Non-Current Assets sank 82.56%; it then surged 1133.33% in 2023.
- Year by year, Other Non-Current Assets stood at $15000.0 in 2022, then surged by 1133.33% to $185000.0 in 2023, then changed by 0.0% to $185000.0 in 2024, then climbed by 5.95% to $196000.0 in 2025, then rose by 2.55% to $201000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $201000.0 in Q3 2026, $212000.0 in Q2 2026, and $196000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 25.20 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 117.41 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 587.56 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 91.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.28 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 87.48 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 201,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 91,801.74 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 143,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 201,000.00 |
| Apr 30, 2026 | 212,000.00 |
| Jan 31, 2026 | 196,000.00 |
| Oct 31, 2025 | 196,000.00 |
| Jul 31, 2025 | 196,000.00 |
| Apr 30, 2025 | 196,000.00 |
| Jan 31, 2025 | 185,000.00 |
| Oct 31, 2024 | 185,000.00 |
| Jul 31, 2024 | 185,000.00 |
| Apr 30, 2024 | 185,000.00 |
| Jan 31, 2024 | 185,000.00 |
| Oct 31, 2023 | 185,000.00 |
| Jul 31, 2023 | 184,000.00 |
| Apr 30, 2023 | 15,000.00 |
| Jan 31, 2023 | 15,000.00 |
| Oct 31, 2022 | 15,000.00 |
| Jul 31, 2022 | 15,000.00 |
| Apr 30, 2022 | 15,000.00 |
| Jan 31, 2022 | 15,000.00 |
| Oct 31, 2021 | 15,000.00 |